Home
Groups
Pages
Marketplace
See More
Groups Pages Marketplace Events Blogs Funding Offers Courses
Sign In Sign Up
Night Mode
Urokinase API and Finished Dosage Forms Market to Reach US$ 3.60 Billion by 2031, Driven by Rising Thromboembolic Disorders
The global Urokinase API and Finished Dosage Forms Market is projected to reach US$ 3.60 billion by 2031, growing from US$ 2.37 billion in 2024 at a CAGR of 6.3% (2025–2031), according to The Insight Partners. The market’s expansion is fueled by the increasing incidence of cardiovascular and thrombotic disorders—including deep vein thrombosis (DVT), pulmonary embolism (PE),...
0 Comments ·0 Shares ·9 Views ·0 Reviews
Please log in to like, share and comment!